Last reviewed · How we verify
Staphylococcal endocarditis
Approved treatments
- Cefaprin · Bristol-Myers Squibb
- Nallpen In Plastic Container · Pfizer
- Vancocin · ANI Pharmaceuticals
- Nallpen In Plastic Container · Pfizer
- Unasyn · Bristol-Myers Squibb
- Bactocill In Plastic Container · Apothecon
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Staphylococcal endocarditis patent landscape — cliff calendar, originator estates, attackable patents
- Staphylococcal endocarditis treatment landscape brief
- Staphylococcal endocarditis treatment updates RSS
Frequently asked questions about Staphylococcal endocarditis
What drugs treat Staphylococcal endocarditis?
Tracked treatments include Cefaprin, Nallpen In Plastic Container, Vancocin, Unasyn, Bactocill In Plastic Container.
What is the treatment for Staphylococcal endocarditis?
Standard treatment for Staphylococcal endocarditis includes Cefaprin, Nallpen In Plastic Container, Vancocin, Unasyn, Bactocill In Plastic Container. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Staphylococcal endocarditis patent cliff · Staphylococcal endocarditis CI report
- Treatment: Cefaprin · Bristol-Myers Squibb
- Treatment: Nallpen In Plastic Container · Pfizer
- Treatment: Vancocin · ANI Pharmaceuticals
- Treatment: Nallpen In Plastic Container · Pfizer
- Treatment: Unasyn · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing